RxDoctor Payments Data

Dana Mann

Family · New Albany, INNPI 1972995314

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 752 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,191in general payments, 2019–2025

Across 752 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Johnson & Johnson$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Pfizer$932
  • plus $4K from 21 others

What the payments were for

  • Food & beverage$13,04699%
  • Education$1451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,191 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$1,033,695
Medicare patients
477
Services billed
84,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab49$352,543
Orencia ClickjectAbatacept17$99,896
Hydroxychloroquine Sulfate510$17,929
MethotrexateMethotrexate Sodium390$9,224
Leflunomide97$6,031
Celecoxib133$4,932
Duloxetine Hcl127$1,887
Colchicine28$1,584
Prednisone196$1,213
Pilocarpine Hcl16$1,101
Meloxicam100$656
Leucovorin Calcium28$412
Diclofenac Sodium26$304
Sulfasalazine11$254
Gabapentin26$209

Paid to pharmacies, not to this prescriber.

Other family in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →